{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T10:14:40Z","timestamp":1760609680881,"version":"build-2065373602"},"reference-count":12,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejinme.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.ejim.2023.07.035","type":"journal-article","created":{"date-parts":[[2023,8,8]],"date-time":"2023-08-08T02:33:51Z","timestamp":1691462031000},"page":"36-37","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["AMA-positivity in AIH-patients with bile duct lesions running in between. Novel findings and perspectives"],"prefix":"10.1016","volume":"116","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5359-1471","authenticated-orcid":false,"given":"Piero","family":"Portincasa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonilde","family":"Bonfrate","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5476-7376","authenticated-orcid":false,"given":"Agostino","family":"Di Ciaula","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2023.07.035_bib0001","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/hep.31065","article-title":"Diagnosis and management of autoimmune hepatitis in adults and children: 2019 practice guidance and guidelines from the american association for the study of liver diseases","volume":"72","author":"Mack","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.ejim.2023.07.035_bib0002","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s00005-019-00550-9","article-title":"Variant and specific forms of autoimmune cholestatic liver diseases","volume":"67","author":"Dalekos","year":"2019","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"10.1016\/j.ejim.2023.07.035_bib0003","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/ng.627","article-title":"Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis","volume":"42","author":"Liu","year":"2010","journal-title":"Nat Genet"},{"key":"10.1016\/j.ejim.2023.07.035_bib0004","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/gene.2013.1","article-title":"Pathway-based analysis of primary biliary cirrhosis genome-wide association studies","volume":"14","author":"Kar","year":"2013","journal-title":"Genes Immun"},{"key":"10.1016\/j.ejim.2023.07.035_bib0005","doi-asserted-by":"crossref","first-page":"8019","DOI":"10.1038\/ncomms9019","article-title":"International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways","volume":"6","author":"Cordell","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.ejim.2023.07.035_bib0006","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1097\/MEG.0000000000000870","article-title":"Clinical implications of antimitochondrial antibody seropositivity in autoimmune hepatitis: a multicentre study","volume":"29","author":"Muratori","year":"2017","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.ejim.2023.07.035_bib0007","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s12016-021-08904-y","article-title":"Antimitochondrial antibodies: from bench to bedside","volume":"63","author":"Colapietro","year":"2022","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.ejim.2023.07.035_bib0008","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/hep.510280203","article-title":"Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: clinical features and response to therapy","volume":"28","author":"Chazouill\u00e8res","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.ejim.2023.07.035_bib0009","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/apt.15111","article-title":"Review article: unanswered clinical and research questions in autoimmune hepatitis-conclusions of the International Autoimmune Hepatitis Group Research Workshop","volume":"49","author":"Dyson","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.ejim.2023.07.035_bib0010","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ejim.2023.06.001","article-title":"Prevalence and significance of antimitochondrial antibodies in autoimmune hepatitis (AIH): results from a large multicentre study of the International AIH Group","volume":"116","author":"Gatselis","year":"2023","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.ejim.2023.07.035_bib0011","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1002\/hep.1840180435","article-title":"Meeting report: international autoimmune hepatitis group","volume":"18","author":"Johnson","year":"1993","journal-title":"Hepatology"},{"key":"10.1016\/j.ejim.2023.07.035_bib0012","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/hep.22438","article-title":"The challenge of diagnosing autoimmune hepatitis: less is more","volume":"48","author":"Choi","year":"2008","journal-title":"Hepatology"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620523002662?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620523002662?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T09:39:21Z","timestamp":1760607561000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620523002662"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":12,"alternative-id":["S0953620523002662"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2023.07.035","relation":{},"ISSN":["0953-6205"],"issn-type":[{"type":"print","value":"0953-6205"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"AMA-positivity in AIH-patients with bile duct lesions running in between. Novel findings and perspectives","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2023.07.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}